Showing results (3281-3290 of 5,709) with videos related to

Sort By:
Pageof 571
BMC Nephrology|July 24, 2021
Community- versus hospital-acquired acute kidney injury in hospitalised COVID-19 patientsJack S Bell, Benjamin D James, Saif Al-Chalabi, et al.
BMC Nephrology|June 17, 2021
Von Willebrand factor, ADAMTS13 and mortality in dialysis patientsGurbey Ocak, Mark Roest, Marianne C Verhaar, et al.
BMC Nephrology|June 17, 2021
Diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional studyRanda I Farah, Mohammed Q Al-Sabbagh, Munther S Momani, et al.
BMC Nephrology|December 2, 2017
Renal association clinical practice guideline on Anaemia of Chronic Kidney DiseaseAshraf Mikhail, Christopher Brown, Jennifer Ann Williams, et al.
BMC Nephrology|May 23, 2023
Total cholesterol and mortality in peritoneal dialysis: a retrospective cohort studyJunnan Wu, Ruifeng Yang, Xiaoyang Wang, et al.
BMC Nephrology|May 26, 2023
Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approachSong Wang, Zhenling Deng, Yue Wang, et al.
BMC Nephrology|May 26, 2023
The diagnostic value of DMSA scan in differentiating functional pseudo-tumors from malignancies in scarred kidneys: case series and literature reviewEnas Hussein Mohammed, Ahmad Kaddourah, Noor Al Khori, et al.
BMC Nephrology|May 26, 2023
Membranous nephropathy caused by dimercaptosuccinic acid in a patient with Wilson's disease: a case report and literature reviewXiang Li, FengXin Hu, Gaosi Xu
BMC Nephrology|April 22, 2023
Risk factors of immune checkpoint inhibitor-associated acute kidney injury: evidence from clinical studies and FDA pharmacovigilance databasePengwei Chen, Jianhong Zhu, Yanchun Xu, et al.
BMC Nephrology|December 24, 2003
Medication-related problem type and appearance rate in ambulatory hemodialysis patientsHarold J Manley, Debra K Drayer, Richard S Muther
Pageof 571